Profiles

BIOTECanada

BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario.^[1] It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.^[2]^[3]

BIOTECanada and the University of Western Ontario jointly administer the Gold Leaf Awards, presented annually to individuals and organizations who are deemed to have made significant contributions to Canada's biotechnology sector.^[4]

History

The organization was incorporated in 1987 as the Industrial Biotechnology Association of Canada.^[5]

Health Canada partnered with BIOTECanada in May 2012 to organize a summit on clinical and regulatory topics associated with biosimilars.^[6] The event was held in association with the International Alliance for Biological Standardization, and was observed by representatives from the Patented Medicine Prices Review Board (PMPRB) and the Canadian Agency for Drugs and Technologies in Health (CADTH). Panelists included representatives from academia, regulatory bodies and industry, such as UMass Memorial Health, Janssen Pharmaceuticals, the Robarts Research Institute, Alberta Blue Cross, Mount Sinai Hospital and Sunnybrook Health Sciences Centre.^[6:1]

In 2017, BIOTECanada published a report detailing proposed initiatives to use biotechnology to address issues including population growth, climate change, food security, health, and economic instability.^[7] President and CEO Andrew Casey sent a letter in July 2017 to Innovation, Science and Economic Development Canada (ISED) proposing measures to offset costs of patent filings, and to reduce taxation on intellectual property revenues.^[3:1]

COVID-19

Several representatives of BIOTECanada participated as members and advisors in the COVID-19 Therapeutics Task Force convened by Innovation, Science and Economic Development Canada.^[8] BIOTECanada participated in the Faster Together campaign to promote COVID-19 vaccines.^[9]

In June 2022, BIOTECanada hosted the Canada Pavilion at the BIO International Convention, an annual biotechnology conference led by the Biotechnology Innovation Organization (BIO).^[10]

Organization

BIOTECanada is partnered with Avantor, Borden Ladner Gervais (BLG), Ontario Genomics,^[11] Silicon Valley Bank (SVB), and Wilson Sonsini Goodrich & Rosati.^[12] The organization is a supporting member of BioTalent Canada, a professional network for the biotechnology community.^[2:1] It is also a member of the Biotechnology Innovation Organization (BIO),^[13] and a founding institution of Clinical Trials Ontario.^[14] It is a participating organization of the Virtual Biosecurity Center, an initiative of the Federation of American Scientists.^[15]

Personnel

Name	Position	Notes
Andrew Casey	President and Chief Executive Officer^[3:2]	-
Mark Lievonen	Board Chair (former)^[16]	COVID-19 Vaccine Task Force, JML Advisory Services, Sanofi Pasteur, Council of Expert Advisors (CEA), Innovative Medicines Canada (IMC)
Anita Hammer	-	Pharmaceutical Advertising Advisory Board (PAAB)^[17]

Members

Current and former member organizations of BIOTECanada include:^[18]^[19]^[20]

3Sixty Public Affairs
35Pharma
48Hour Discovery
A&C American Chemicals
AbbVie
AbCellera
Abdera Therapeutics
Ability Biologics
Accel-Rx
Actylis
Acuitas Therapeutics
Adapsyn Bioscience
adMare BioInnovations
Advanced Accelerator Applications
Aegerion Pharmaceuticals
Ag-West Bio
Agricultural Institute of Canada (AIC)
Agri-Food Innovation Council (AIC)
Agrisoma Biosciences
Akshaya Bio
Alethia Biotherapeutics
Alexandria Venture Investments
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Alpha Cancer Technologies
Alpha Cognition
Alpha9 Theranostics
Altus Formulation
AmacaThera
Amgen
AmorChem
Amplitude Ventures
Antibe Therapeutics
Aplantix
Appili Therapeutics
Applied Pharmaceutical Innovation (API)
AquaBounty
Aquinox Pharmaceuticals
Aramis Biotechnologies
AREV Life Sciences
Aspect Biosystems
AstraZeneca
AtomVie Global Radiopharma
Atuka
Augurex Life Sciences
Aurinia Pharmaceuticals
AusBiotech
Avir Pharma
Back Bay Life Science Advisors (BBLSA)
Bayer
Bayshore Specialty Rx
BeiGene
BELLUS Health
BioAlberta
BioAmber
BioCanRx
Biodextris
Bioenterprise
Biogen
Bioindustrial Innovation Canada
Bio-K Plus
Biologics Manufacturing Centre (BMC)
BioMarin
BioMark Diagnostics
BioNB
BioNova Pharmaceuticals
Biopharm Management
BIOQuébec
Bioscience Association Manitoba (BAM)
BioSignal2
BioTalent Canada
BioTech New Zealand
Biotechnology Innovation Organization (BIO)
BIOVECTRA
Blake, Cassels & Graydon
Blanchard Law
Bloom Burton & Co.
BMS Group
Bold Therapeutics
Borden Ladner Gervais (BLG)
BrevisRefero
Bright Angel Therapeutics
Bristol-Myers Squibb
BSQUARED Capital
Canadian Advanced Therapies Training Institute (CATTI)
Canadian Alliance for Skills and Training in Life Sciences (CASTL)
Canadian Glycomics Network (GlycoNet)
Canadian Seed Trade Association (CSTA)
Canadian Venture Capital & Private Equity Association (CVCA)
Canurta
Caprion Biosciences
Cardiome Pharma
case Market Access Consulting
CBRE Group
Ceapro
Celator Pharmaceuticals
Celgene
Celverum
Centre for Commercialization of Regenerative Medicine (CCRM)
Centre for Drug Research and Development (CDRD)
Centre for Probe Development and Commercialization (CPDC)
Centre for the Commercialization of Antibodies and Biologics (CCAB)
Chelation Partners
Chinook Therapeutics
CO2 Solutions
Consortium de recherche biopharmaceutique (CQDM)
Contextual Genomics
Critical Outcome Technologies
CryoStasis
CSL Behring
CSL Seqirus
CTI Life Sciences Fund
Cura Therapeutics
Cyclenium Pharma
Cynapsus Therapeutics
Daiichi-Sankyo
Dalton Pharma Services
Defence Therapeutics
DelMar Pharmaceuticals
Deloitte
Domain Therapeutics
Drug Development and Innovation Centre (DDIC)
Eisai
Eli Lilly
Encycle Therapeutics
enGene
Entos Pharmaceuticals
Epitopea
Ernst & Young (EY)
ESSA Pharma
EVERSANA
Evolution for Animal Health (EVAH)
Evolve Therapeutics
ExCellThera
Farris
Fasken Martineau DuMoulin
Feldan Therapeutics
Ferring Pharmaceuticals
FGS Longview
Fibrocor Therapeutics
Find Therapeutics
Fonds de solidarité FTQ
Formation Biologics
FORUS Therapeutics
Fusion Pharmaceuticals
Genentech
GenePOC
Genesys Capital
Genome Canada
Genvira Biosciences
Genzyme
Giiant Pharma
Gilead Sciences
Global Public Affairs
GMD Pharma Solutions
GoodCap Pharmaceuticals
Gowling WLG
Grifols
Guthrie Insurance Brokers
HDAX Therapeutics
Highland Therapeutics
Horizon Pharma
HTuO Biosciences
Immugenia
Immune Biosolutions
ImmunoCalyx
ImStar Therapeutics
IMV
Incyte
Innovation PEI
Innovative Targeting Solutions
InnovoXL
InSymbiosis Management
Integrated Nanotherapeutics
Inteligex
Intercept Pharmaceuticals
International Centre for Infectious Diseases (ICID)
Intrinsik Health Sciences
Inversago Pharma
Iprogen Biotech
Ipsen Biopharmaceuticals
IQVIA
IRICoR
iTP Biomedica
Janssen
Jazz Pharmaceuticals
JLABS
JN Nova
JPMorgan Chase
Kaléo
KalGene Pharmaceuticals
Kane Biotech
Kapoose Creek Bio
KisoJi Biotechnology
Kisolite
KMT Hepatech
KOP Therapeutics
Korea Biotechnology Innovation Organization
KPMG
KreaMedica
Langara College
Laurent Pharmaceuticals
Life Sciences British Columbia
Life Sciences Ontario
Linnaeus Plant Sciences
LQT Therapeutics
Lumira Ventures
Mallinckrodt Pharmaceuticals
Mannin Research
MaRS Discovery District
McDougall Scientific
McKesson Canada
ME Therapeutics
MEDEC
MedGenesis Therapeutix
Medicago
Medicenna Therapeutics
Medicure
Mediphage Bioceuticals
Medlior Health Outcomes Research
Medtech Canada
Medunik Canada
Medwell Capital
Merck
MSI Methylation Sciences
Microbion Pharma
Milestone Pharmaceuticals
Mitsubishi Tanabe
Modelis
Moderna
Molecular Forecaster
MORSE Consulting
Nanology Labs
Nanovista
National Research Council Canada (NRC)
Neolys Pharma
NEOMED Institute
Neova Technologies
NervGen Pharma
Neurenati Therapeutics
Neurodyn Life Sciences
Newfoundland and Labrador Association of Technology Industries (NATI)
Noa Therapeutics
Nobelex Biotech
Northern Biologics
Northwest Biotherapeutics
Norton Rose Fulbright
Notch Therapeutics
Novartis
Novavax
Novicol Life Sciences
Novo Nordisk
Oak Bay Biosciences
Okanagan Specialty Fruits
Oncolytics Biotech
Ontario Bioscience Innovation Organization (OBIO)
Optigo Biotherapeutics
Orion Biotechnology
Pangaea Group
Pan-Provincial Vaccine Enterprise (PREVENT)
Patient Access Solutions
Pattern Pharma
PBR Laboratories
PDCI Market Access
Pegasus Biotech
Pfizer
Phenomic AI
Phoenix Molecular Designs
Pholoho Biotechnology
PlantForm
POS Bio-Sciences
Precision NanoSystems
PreciThera
Prevtec Microbia
Primary Peptides
Prince Edward Island BioAlliance
Pro Bono Bio
ProMIS Neurosciences
ProNAi Therapeutics
PROOF Centre of Excellence
ProteinQure
Proteocyte Diagnostics
Qu Biologics
Quality & Compliance Services
Quark Venture
QurCan Therapeutics
Radiant Biotherapeutics
Raptor Pharmaceuticals
Reciprocal Space
Red Leaf Medical
Renaissance BioScience
Repare Therapeutics
RepliCel Life Sciences
Replikins
Research Canada
Research New Brunswick
Resverlogix
Ripple Therapeutics
ROCADE Investments
Roche
Roubaix Strategies
Royal Bank of Canada (RBC)
Sanofi
SaNOtize
Sansero Life Sciences
ScarX Therapeutics
Scispot
Seagen
Seeds Canada
SemaThera
Seqirus
Sequence Bio
Sernova
SeroGene Therapeutics
Servier
Shadow Lake Group
Shoppers Drug Mart Specialty Health Network (SDMSHN)
Sierra Oncology
SignalChem Lifesciences
Silicon Valley Bank (SVB)
SinoVeda
Smart & Biggar
Soricimed Biopharma
Sound Insurance Services
Specific Biologics
SPharm
Spiderwort
Sustained Therapeutics
Swedish Orphan Biovitrum (Sobi)
TACT Intelligence-conseil
Taiho Pharma Canada
Takeda Pharmaceuticals
Tallc
Targa Biomedical
TEC Edmonton
techNL
Temple Therapeutics
Tentarix Biotherapeutics
Teralys Capital
Tetra Bio-Pharma
Teva Pharmaceuticals
Therapure Biopharma
Thrasos
Thryv Therapeutics
Tieös Pharmaceuticals
Toronto Innovation Acceleration Partners (TIAP)
Transbiotech
Transition Therapeutics
Trillium Therapeutics
Triphase Accelerator
Triple Hair
Turnstone Biologics
UCB
Ultragenyx
University Health Network (UHN)
University of Guelph
University of Manitoba
University of Waterloo
Valeant
Valneva
Vasomune Therapeutics
VBI Vaccines
Ventus Therapeutics
VeriLuce Therapeutics
Verity Pharmaceuticals
Versant Ventures
Vertex Pharmaceuticals
viDA Therapeutics
VIDO-InterVac
Virica Biotech
Virogin Biotech
Viventia Bio
VoxCell BioInnovation
VWR International
Wex Pharmaceuticals
Wilson Sonsini Goodrich & Rosati
Xagenic
Xenon Pharmaceuticals
Zenith Epigenetics
Zucara Therapeutics
Zymeworks

Activities

BIOTECanada has provided notable funding to the C.D. Howe Institute.^[21]

External links

MacDonald, C. (2004). Business Ethics 101 for the biotech industry. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 18(2), 71–77. https://doi.org/10.2165/00063030-200418020-00001 ↩︎
BIOTECanada. BioTalent Canada. Retrieved September 1, 2022, from https://archive.vn/20220901170514/https://www.biotalent.ca/organizations/biotecanada-2/ ↩︎ ↩︎
Casey, A. (2017, July 17). RE: Canada’s New Intellectual Property Strategy. Innovation, Science and Economic Development Canada. https://web.archive.org/web/20220902053734/https://www.ic.gc.ca/eic/site/693.nsf/vwapj/BIOTECanada.pdf/$file/BIOTECanada.pdf ↩︎ ↩︎ ↩︎
BIOTECanada Gold Leaf Awards. University of Western Ontario. Retrieved September 1, 2022, from https://web.archive.org/web/20220901171104/https://www.uwo.ca/research/impact/awards/biotecanada_gold_leaf_awards.html ↩︎
BIOTECanada. Bioscience Association Manitoba. Retrieved September 1, 2022, from https://web.archive.org/web/20220901204111/https://www.biomb.ca/bioscape/303/biotecanada ↩︎
Kay, J., Feagan, B. G., Guirguis, M. S., Keystone, E. C., Klein, A. V., Lubiniecki, A. S., Mould, D. R., Nyarko, K. A., Ridgway, A. A. G., Trudeau, M. E., & Wang, J. (2012). Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012. Biologicals, 40(6), 517–527. https://doi.org/10.1016/j.biologicals.2012.09.010 ↩︎ ↩︎
The Science of Amazing Canada’s Biotech Ecosystem. (2017). BIOTECanada. https://web.archive.org/web/20220901204805/https://www.biotecanada-ecosystem.com/ ↩︎
Innovation, Science and Economic Development Canada. (2022, March 10). COVID-19 Therapeutics Task Force. Government of Canada. https://web.archive.org/web/20230427230210/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force ↩︎
Home. Faster Together. Retrieved November 29, 2022, from https://web.archive.org/web/20221129144335/https://fastertogether.ca/ ↩︎
Alberta at BIO International 2022. BioAlberta. Retrieved September 1, 2022, from https://web.archive.org/web/20220901171800/https://www.bioalberta.com/alberta-at-bio-international-2022 ↩︎
Other Partners. Ontario Genomics. Retrieved May 2, 2022, from https://www.ontariogenomics.ca/about-us/partners/other-partners/ ↩︎
About. BIOTECanada. Retrieved August 2, 2022, from https://web.archive.org/web/20220802194749/https://www.biotech.ca/about/ ↩︎
BIOTECanada. Biotechnology Innovation Organization. Retrieved June 21, 2024, from https://web.archive.org/web/20240621201653/https://www.bio.org/save/biotecanada ↩︎
Founding Institutions. Clinical Trials Ontario. Retrieved December 30, 2024, from https://web.archive.org/web/20241230212232/https://legacy.ctontario.ca/who-we-are-clinical-trials-ontario/founding-institutions/ ↩︎
BIOTECanada. Virtual Biosecurity Center. Retrieved September 1, 2022, from https://web.archive.org/web/20220901204417/https://www.virtualbiosecuritycenter.org/organizations/biotecanada/ ↩︎
J. Mark Lievonen. Vaccine and Infectious Disease Organization. Retrieved December 30, 2024, from https://www.vido.org/team/board-of-directors/mark-lievonen ↩︎
About. Pharmaceutical Advertising Advisory Board / Conseil Consultatif de Publicité Pharmaceutique. Retrieved August 28, 2022, from https://web.archive.org/web/20220828145658/https://www.paab.ca/about.htm ↩︎
Member Listings. BIOTECanada. Retrieved December 21, 2021, from https://web.archive.org/web/20211221183627/https://www.biotech.ca/about/member-listings/ ↩︎
Member Listings. BIOTECanada. Retrieved December 30, 2024, from https://web.archive.org/web/20241230035335/https://www.biotech.ca/about/member-listings/ ↩︎
Member Listings. BIOTECanada. Retrieved July 14, 2016, from https://web.archive.org/web/20160714185759/https://www.biotech.ca/about/member-listings/ ↩︎
MacKinnon, H. L., & Robson, W. B. P. Annual Report 2017. C.D. Howe Institute. Retrieved November 9, 2022, from https://web.archive.org/web/20221109192109/https://www.cdhowe.org/sites/default/files/2022-04/2017 AR_English_Final_web.pdf ↩︎

Categories